Interleukin-1β Accelerates the Onset of Stroke in Stroke-Prone Spontaneously Hypertensive Rats

Figure 3

Effect of continuous administration of IL-1β on the incidence of stroke in SHR. SHR (male, 10 weeks of age) were given IL-1β (2 μg/day) or vehicle (phosphate-buffered saline) for 4 weeks using osmotic pumps. Photograph of typical hemorrhage lesion in SHR given IL-1β for 4 weeks.